Boston Partners Integra Lifesciences Holdings Corp Transaction History

Boston Partners

$80.7 Billion
Q1 2024

A detailed history of Boston Partners transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Boston Partners holds 561,942 shares of IART stock, worth $16.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

561,942

Previous 561,942 -0.0%

Holding current value

$16.4 Million

Previous $19.9 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$33.4 - $45.2 $18.8 Million - $25.4 Million	561,942 New	561,942 $19.9 Million
Q2 2020 Aug 12, 2020	SELL	$41.42 - $55.57 $538,501 - $722,465	-13,001 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$36.67 - $61.04 $4,693 - $7,813	128 Added 0.99%	13,001 $581,000
Q4 2019 Feb 05, 2020	SELL	$55.73 - $62.49 $13,709 - $15,372	-246 Reduced 1.88%	12,873 $750,000
Q2 2019 Aug 09, 2019	BUY	$46.45 - $55.85 $7,942 - $9,550	171 Added 1.32%	13,119 $733,000

Q1 2019 May 03, 2019	SELL	$42.97 - $57.33 $334,822 - $446,715	-7,792 Reduced 37.57%	12,948 $721,000
Q4 2018 Feb 07, 2019	SELL	$42.62 - $64.51 $9.82 Million - $14.9 Million	-230,443 Reduced 91.74%	20,740 $935,000
Q3 2018 Nov 14, 2018	SELL	$57.63 - $65.87 $310,913 - $355,368	-5,395 Reduced 2.1%	251,183 $16.5 Million
Q2 2018 Aug 03, 2018	BUY	$54.05 - $67.23 $147,178 - $183,067	2,723 Added 1.07%	256,578 $16.5 Million
Q1 2018 May 04, 2018	SELL	$46.55 - $57.38 $6.82 Million - $8.4 Million	-146,441 Reduced 36.58%	253,855 $14 Million
Q4 2017 Feb 01, 2018	BUY	$46.22 - $51.77 $1.31 Million - $1.47 Million	28,408 Added 7.64%	400,296 $19.2 Million
Q3 2017 Nov 02, 2017	BUY	$47.8 - $53.63 $17.8 Million - $19.9 Million	371,888	371,888 $18.8 Million

Others Institutions Holding IART

# of Institutions

295

Shares Held

69.9M

Call Options Held

20.2K

Put Options Held

9.3K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $2.43B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account